Mackenzie Financial’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-36,001
Closed -$639K 1724
2025
Q1
$639K Buy
36,001
+6,515
+22% +$140K ﹤0.01% 1119
2024
Q4
$631K Buy
+29,486
New +$717K ﹤0.01% 1077
2022
Q1
Sell
-5,626
Closed -$256K 1423
2021
Q4
$256K Buy
5,626
+653
+13% +$34.1K ﹤0.01% 1224
2021
Q3
$315K Buy
4,973
+1,410
+40% +$107K ﹤0.01% 1117
2021
Q2
$326K Buy
+3,563
New +$283K ﹤0.01% 1052

Other funds holding CDNA

Mackenzie Financial's CDNA Position: Q2 2025 in Review

Mackenzie Financial sold out of CareDx (CDNA) in Q2 2025, closing a stake of 36,001 shares — an estimated $639K sold.

Mackenzie Financial first reported a position in CDNA in Q2 2021 and held it in 5 quarters. The position peaked at $639K in Q1 2025. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

  • Mackenzie Financial reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
  • Mackenzie Financial sold 36,001 CareDx shares in Q2 2025, an estimated $639K.
  • Mackenzie Financial first reported a position in CareDx in Q2 2021 and held it in 5 quarters.
  • Mackenzie Financial's CareDx position peaked at $639K in Q1 2025.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Mackenzie Financial's 13F filing for Q2 2025, filed 13 Aug 2025.